About this Research Topic
Inflammatory T cells play an important role in initiating and promoting the inflammatory response against self-antigens, or increasing antigen mimicry effects. Th17 are important inflammatory T cell subsets, differentiated from naïve T helper cells in response to the production of inflammatory cytokines such as IL-6 and IL-23. They have been linked to the progression of several autoimmune pathologies, including multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus.
Regulatory T cells (Treg) are essential in maintaining the homeostasis of immune responses. They are the main subset of T cells that keep the body from developing autoimmune responses and help produce central and peripheral tolerance. Treg cells primarily modulate the immune response through surface contact and cytokine production. A Treg cell is a CD3+, CD4+, CD25+, and Foxp3+ T-cell, which can decrease inflammation in patients with several autoimmune diseases.
A deeper understanding of the immune response in autoimmune diseases can aid in the clinical intervention and treatment process. In autoimmune binaries, dependent on the type of disease, subclasses Th1, Th2, and Th17 can be activated, and their suppression process can be effective in the treatment of diseases. This Research Topic aims to assemble studies investigating the function of different subtypes of T cells in autoimmune diseases.
We welcome the submission of articles that explore the mechanisms involved in the responses of T cells in autoimmune diseases, as well as the interaction between these cells. The effect of drugs and clinical interventions in autoimmune diseases and their effect on T cell subclasses are also of interest.
Keywords: Immune system, T cell subsets, T helper cells, Autoimmune diseases
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.